Starpharma Holdings LimitedASX: SPL

SPL receives positive FDA feedback on DEP SN38 for PROC

Dec 19, 2024 at 4:02 AM UTC · Issued by Starpharma Holdings Limited

Starpharma Holdings Ltd has released a press release.

View Attachment